Subscribe
shutterstock_1179311575_vchal
Vchal / Shutterstock.com
30 September 2019AmericasSarah Morgan

Taiwanese firm accuses Pacific Biosciences of infringing sequencing tech

In its suit, filed at the US District Court for the District of Delaware on Thursday, September 26, PGI accused Pacific Biosciences of infringing US patent 7,767,441 through the sale of its nucleic acid sequencing platform Sequel System.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Illumina buys rival Pacific Biosciences for $1.2bn
2 November 2018   Gene-sequencing company Illumina has agreed to buy competitor Pacific Biosciences for $1.2 billion.
Asia
Personal Genomics takes PacBio dispute to Chinese court
22 May 2020   Taiwanese biotechnology company Personal Genomics is using California’s Pacific Biosciences for patent infringement in China.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Americas
Illumina buys rival Pacific Biosciences for $1.2bn
2 November 2018   Gene-sequencing company Illumina has agreed to buy competitor Pacific Biosciences for $1.2 billion.
Asia
Personal Genomics takes PacBio dispute to Chinese court
22 May 2020   Taiwanese biotechnology company Personal Genomics is using California’s Pacific Biosciences for patent infringement in China.

More on this story

Americas
Illumina buys rival Pacific Biosciences for $1.2bn
2 November 2018   Gene-sequencing company Illumina has agreed to buy competitor Pacific Biosciences for $1.2 billion.
Asia
Personal Genomics takes PacBio dispute to Chinese court
22 May 2020   Taiwanese biotechnology company Personal Genomics is using California’s Pacific Biosciences for patent infringement in China.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent